The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect

Overview of attention for article published in Cardiovascular Diabetology, November 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (61st percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 40 Dimensions

Readers on

mendeley: 84 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 2,845 followers.

@DrEenfeldt https://t.co/rjVhDd4aNM.

16 Jun 2023

Reply Repost Favourite

https://t.co/muQXNGTuJX 　より引用改変。…

16 Apr 2023

Reply Repost Favourite

The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect https://t.co/lgDHwU2lw4 Excelente grupo farmacológico Nos esperan buenos resultado

29 Nov 2021

Reply Repost Favourite

The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect https://t.co/egx4lhuKGq

25 Nov 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.